In muscle-invasive BC higher counts of tumour-infiltrating CD3 and CD8 lymphocytes have been linked to favourable disease outcomes (12, 25–27) and even to a higher response rate to neoadjuvant chemotherapy (27). This evidence concerns the gene CD8A and neoplasm.